ArticleAdalimumab for Hidradenitis SuppurativaAuthor:Daniel J. No, BAPublish date: August 2, 2017We applaud Kimball et al1 on their report that adalimumab demonstrated clinical improvement in patients with hidradenitis suppurativa (H...Read More
ArticleBSA75, BSA90, and BSA100: New Clinical Tools for Measuring Improvement in PsoriasisAuthor:Daniel J. No, BAPublish date: June 2, 2017Currently, there is no widely accepted tool for assessing the severity of psoriasis in the clinical setting.1-5 Moreover, there is still a need for...Read More
ArticleThe Role of Biologic Therapy for Psoriasis in Cardiovascular Risk ReductionAuthor:Daniel J. No, BAPublish date: February 3, 2017The cardiovascular comorbidities associated with psoriasis have been well documented; however, the mechanism by which psoriasis increases the risk ...Read More
